Women's Longevity: Hormones, Bone, Heart & Sex-Specific Biomarkers

The short version

Women's longevity protocols differ meaningfully from men's. Estradiol and progesterone optimization (or bioidentical replacement when appropriate) is foundational. Bone density becomes a primary endpoint after age 40. Iron status matters more in cycling years and changes meaningfully post-menopause. The protocol on this page is built specifically for women, not adapted from a male template.

Why this protocol works

The strongest predictors of all-cause mortality in women — beyond chronological age — are: ApoB (cardiovascular), HbA1c + fasting insulin (metabolic), bone mineral density (DEXA scan), and vitamin D (independent predictor). Hormone status (estradiol, progesterone, DHEA-S) drives both bone and cardiovascular outcomes; restoring them in early peri-menopause has the strongest published longevity signal.

The peptide foundation is similar to the unisex longevity protocol — Epithalon (telomere data), MOTS-c (mitochondrial), GHK-Cu (cellular rejuvenation) — but the supplement stack adds calcium 600mg + vitamin K2 100mcg + magnesium 400mg for bone, and iron 18mg if cycling and not iron-replete.

The biomarkers that women specifically need: estradiol (tracking through perimenopause), DHEA-S, bone density via DEXA quarterly-to-yearly, ApoB, HbA1c, vitamin D, ferritin (especially in cycling women — iron deficiency is endemic and undertreated).

Peptides commonly used for women's longevity

Supplement stack pairing

Biomarkers to track for women's longevity

The protocol

1. 1
   Baseline panel: full lipids inc. ApoB + Lp(a), HbA1c, fasting insulin, hs-CRP, homocysteine, vitamin D, B12, ferritin (iron studies if low), estradiol (sensitive assay), progesterone, DHEA-S, full thyroid panel.
2. 2
   DEXA scan baseline — bone density + body composition. Repeat yearly, more often if osteopenic.
3. 3
   Longevity Foundation supplement stack + women's additions: calcium 600mg (food-source preferred), vitamin K2 100 mcg, magnesium glycinate 400mg, iron 18mg if cycling and ferritin <50.
4. 4
   Hormone optimization with a qualified provider in perimenopause. Bioidentical estradiol + progesterone has the strongest longevity-signal data; oral synthetic progestins do not.
5. 5
   Resistance train 3–4x/week. The single biggest lever for bone density and metabolic health in women, full stop.
6. 6
   Re-test panel quarterly (or at minimum annually). Hormone panels need a consistent menstrual-cycle phase or post-menopausal timing for comparability.

Common pitfalls

• ×Using male reference ranges. Optimal estradiol, ApoB, ferritin, and hemoglobin targets all differ between women and men.
• ×Ignoring iron in cycling years. Most women with fatigue have ferritin under 30 and don't know it. Cheap to test, cheap to fix.
• ×Treating bone density as a single-marker problem. DEXA gives one number; what matters is the slope across multiple scans + the calcium/D/K2/training inputs.
• ×Skipping hormone panels in perimenopause. The window where bioidentical replacement has the strongest longevity signal is narrow — track early.

Other goals